Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Aurora Cannabis Inc. (ACB:NASDAQ), powered by AI.
Aurora Cannabis Inc. is currently trading at $3.00. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Aurora Cannabis Inc. on Alpha Lenz.
Aurora Cannabis Inc.'s P/E ratio is 103.4.
“Aurora Cannabis Inc. trades at a P/E of 103.4 (premium valuation) with modest ROE of 0.3%. 3Y revenue CAGR of 15.8% highlights clear growth momentum.”
Ask for details →Aurora Cannabis Inc. is an established player in the medicinal and recreational cannabis industry. With its headquarters in Edmonton, Canada, Aurora operates one of the world's largest facility networks geared towards cannabis production. The primary purpose of Aurora Cannabis is to provide high-quality, affordable products for both medical and adult-use markets, leveraging scientific innovation and cultivation expertise. Notable for impacting the healthcare sector, as it provides medicinal cannabis solutions for conditions like chronic pain and mental health disorders, Aurora also plays a role in the consumer goods sector through recreational product offerings. Aurora's extensive distribution channels span both domestic and international markets, enabling a significant market presence and influence in the global cannabis industry. By pioneering advancements in cultivation technology and product diversity, the company remains an integral entity in the evolving cannabis landscape.
“Aurora Cannabis Inc. trades at a P/E of 103.4 (premium valuation) with modest ROE of 0.3%. 3Y revenue CAGR of 15.8% highlights clear growth momentum.”
Ask for details →Aurora Cannabis Inc. (ticker: ACB) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 1,073 employees. Market cap is $164M.
The current price is $3 with a P/E ratio of 103.39x and P/B of 0.29x.
ROE is 0.28% and operating margin is 2.91%. Annual revenue is $343M.